Brazil: keep an eye on reforms

In the past few years, Brazil ’s economy has not been an auspicious backdrop for equities, yet the market has almost doubled to a six-year high since early 2016. So is the rally justified, and can it endure?

In the past few years, Brazil has suffered its worst recession on record, impeached a president, and discovered that an uncomfortably large proportion of its politicians have been implicated in a kickback scandal at state-owned oil giant Petrobras. This is hardly an auspicious backdrop for equities, yet the market has outperformed all its emerging-market counterparts in the past year. It has almost doubled to a six-year high since early 2016.

So is the rally justified, and can it endure? For starters, "the economy has definitely turned a corner and is moving in the right direction", as Walter Molano of BCP Securities points out. The economy is still shrinking, but the business cycle is clearly on the turn. A survey tracking manufacturing has risen to a two-year high.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.